Clin2
NCT06809179Possibly a fitRecruiting

Nasal spray for social anxiety

Social Anxiety Disorder

Part of Mental health clinical trials.

This study tests if a new nasal spray called fasedienol helps quickly reduce anxiety in adults with social anxiety disorder. The spray is used as needed in a repeat-dose design, meaning you might use it more than once.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 2
Enrollment
60 people
Ages
18 years to 65 years
Study type
Interventional

Who can take part

  • You must be between 18 and 65 years old.
  • You must have a current diagnosis of social anxiety disorder that a doctor has confirmed.
  • You can't have severe depression or a history of bipolar disorder, schizophrenia, or certain eating disorders.
  • You can't have tried two or more approved social anxiety medications that didn't work (unless your doctor tells you it's okay).
  • You must have a normal sense of smell and no major nose injuries or surgeries.
  • You cannot be in talk therapy (CBT, exposure, or acceptance therapy) for anxiety right now, and you must not have taken any anxiety or depression meds in the last 30 days.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06526260Recruiting
Very Brief Exposure for Social Anxiety in Teens and Young Adults

This study tests a very short, new type of exposure therapy for social anxiety in teens and young adults. Participants will also have a brain scan (MRI) to see how the therapy affects the brain.

Los Angeles, California
NCT04663724Recruiting
Computer-based treatment for social anxiety disorder

This study is testing a computer-based treatment for social anxiety disorder. It may help reduce anxiety in social situations through a structured online program, and it also includes brain imaging (MRI) to see how the treatment affects the brain.

New York, New York
NCT05683223Recruiting
Brain and body markers to improve treatment for social anxiety

This study uses brain recordings (EEG and MRI) to understand how treatments help people with social anxiety. It also looks for signals that may predict who is most likely to benefit from treatment.

Boston, Massachusetts
NCT07716098Recruiting· Phase 3
Esketamine nasal spray for treatment-resistant depression

This study tests esketamine nasal spray versus a placebo in adults with depression that has not improved after trying at least two other antidepressants. It aims to see if the spray can help when standard pills have not worked.

Redlands, California
NCT05649059Recruiting· Phase 4
Cannabidiol study for social anxiety symptoms

This trial studies whether cannabidiol (CBD) helps improve social anxiety symptoms. You may be able to join if you are an adult with significant social anxiety and meet medication and health safety requirements.

Cambridge, Massachusetts
NCT06330584Recruiting· Phase 2
Nasal spray for anxiety in palliative care

This trial tests a nasal spray called midazolam to quickly reduce anxiety in people receiving palliative care. If you're an adult in the hospital with sudden anxiety, this could help you feel calmer.

Basel, Canton of Basel-City

Hear when a new Social Anxiety Disorder trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.